PH20768A - New diazabicyclo-(3.3.1)-nonanes and a process for the preparation thereof - Google Patents

New diazabicyclo-(3.3.1)-nonanes and a process for the preparation thereof

Info

Publication number
PH20768A
PH20768A PH29556A PH29556A PH20768A PH 20768 A PH20768 A PH 20768A PH 29556 A PH29556 A PH 29556A PH 29556 A PH29556 A PH 29556A PH 20768 A PH20768 A PH 20768A
Authority
PH
Philippines
Prior art keywords
nonanes
preparation
diazabicyclo
new
substituents
Prior art date
Application number
PH29556A
Other languages
English (en)
Inventor
Uwe Schon
Wolfgang Kehrbach
Gerd Buschmann
Bernd Hachmeister
Ulrich Kuhl
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of PH20768A publication Critical patent/PH20768A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH29556A 1982-09-18 1983-09-16 New diazabicyclo-(3.3.1)-nonanes and a process for the preparation thereof PH20768A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823234697 DE3234697A1 (de) 1982-09-18 1982-09-18 Neue diazabicyclo-(3,3,1)-nonane

Publications (1)

Publication Number Publication Date
PH20768A true PH20768A (en) 1987-04-10

Family

ID=6173602

Family Applications (1)

Application Number Title Priority Date Filing Date
PH29556A PH20768A (en) 1982-09-18 1983-09-16 New diazabicyclo-(3.3.1)-nonanes and a process for the preparation thereof

Country Status (25)

Country Link
US (2) US4550112A (fi)
EP (2) EP0250903B1 (fi)
JP (2) JPS5970686A (fi)
AT (2) ATE45579T1 (fi)
AU (1) AU564910B2 (fi)
CA (1) CA1254209A (fi)
CS (1) CS389891A3 (fi)
DD (1) DD213923A5 (fi)
DE (3) DE3234697A1 (fi)
DK (1) DK165833C (fi)
ES (1) ES8405398A1 (fi)
FI (1) FI76338C (fi)
GE (1) GEP19960316B (fi)
GR (1) GR78722B (fi)
HU (1) HU191096B (fi)
IE (1) IE57580B1 (fi)
IL (1) IL69751A (fi)
MX (1) MX9202996A (fi)
NO (1) NO160516C (fi)
NZ (1) NZ205627A (fi)
PH (1) PH20768A (fi)
PT (1) PT77344B (fi)
SU (1) SU1272989A3 (fi)
UA (1) UA817A1 (fi)
ZA (1) ZA836185B (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3529872A1 (de) * 1985-08-21 1987-02-26 Kali Chemie Pharma Gmbh Neue tetraoxoverbindungen
WO1989000158A1 (en) * 1987-07-02 1989-01-12 Pfizer Inc. Bridged-diazabicycloalkyl quinolone carboxylic acids and esters
DE3722134A1 (de) * 1987-07-04 1989-01-19 Kali Chemie Pharma Gmbh 3-sulfonyl-3,7-diazabicyclo(3,3,1)nonan- verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
PT88381B (pt) * 1987-09-09 1995-07-06 Kali Chemie Pharma Gmbh Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos
DE4019080A1 (de) * 1990-06-15 1991-12-19 Kali Chemie Pharma Gmbh Neue 3,7-diazabicycolo (3,3,1)nonan-verbindungen enthaltende arzneimittel
DE4139763A1 (de) * 1991-12-03 1993-06-09 Kali-Chemie Pharma Gmbh, 3000 Hannover, De Kristalline fumarsaure salze von 9,9-alkylen-3,7-diazabicyclononan-verbindungen und diese verbindungen enthaltende arzneimittel
DE4402933A1 (de) * 1994-02-01 1995-08-03 Kali Chemie Pharma Gmbh Neue 3-Benzoyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel
DE4421324A1 (de) 1994-06-17 1995-12-21 Kali Chemie Pharma Gmbh Neue 3,7-Diazabicyclo [3,3,1] nonan-Verbindungen enthaltende Arzneimittel
SE9704709D0 (sv) 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
US20040229900A1 (en) * 1999-06-16 2004-11-18 Astrazeneca Ab Bispidine compounds useful in the treatment of cardiac arrythmias
US20050004113A1 (en) * 1999-06-16 2005-01-06 Astrazeneca Ab New bispidine compounds useful in the treatment of cardiac arrhythmias
SE9902270D0 (sv) 1999-06-16 1999-06-16 Astra Ab Pharmaceutically active compounds
SE9904765D0 (sv) 1999-12-23 1999-12-23 Astra Ab Pharmaceutically-useful compounds
SE0002603D0 (sv) * 2000-07-07 2000-07-07 Astrazeneca Ab New compounds
US6808924B1 (en) 2000-07-11 2004-10-26 Claudia Lanari Mouse mammary tumor lines expressing estrogen and progesterone receptors
AR030756A1 (es) * 2000-10-02 2003-09-03 Astrazeneca Ab Compuesto de oxabispidina util en el tratamiento de arritmias cardiacas
SE0003795D0 (sv) * 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
SE0100326D0 (sv) * 2001-02-02 2001-02-02 Astrazeneca Ab New compounds
DE10131217A1 (de) * 2001-06-28 2003-01-09 Solvay Pharm Gmbh 3-Phenyl-3,7-diazabicyclo 3,3,1 nonan-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
TW200418468A (en) 2002-11-18 2004-10-01 Solvay Pharm Gmbh Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and method of treatments relating to anti-arrhytmic events
US20050054667A1 (en) * 2003-07-21 2005-03-10 Solvay Pharmaceuticals Gmbh Method of treating or inhibiting anti-arrhythmic events in male human patients
JP2006528155A (ja) * 2003-07-21 2006-12-14 ゾルファイ　ファーマスーティカルズ　ゲゼルシャフト　ミット　ベシュレンクテル　ハフツング ３，７−ジアザビシクロ［３．３．１］ノナン化合物の、ヒト男性患者の抗不整脈事象治療及び／又は予防のための使用
WO2005030207A1 (en) * 2003-09-26 2005-04-07 Solvay Pharmaceuticals Gmbh Use of 3, 7-diazabicyclo (3.3.1) nonane compounds for the treatment of brugada syndrome
SE0302775D0 (sv) * 2003-10-20 2003-10-20 Astrazeneca Ab Chemical compound and assay
SE0401540D0 (sv) * 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401539D0 (sv) 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
CN101243093A (zh) * 2005-06-13 2008-08-13 阿斯利康(瑞典)有限公司 用于治疗心律不齐的新型氧杂双哌啶化合物
US10399926B1 (en) 2018-08-01 2019-09-03 Divi's Laboratories Ltd. Process for the preparation of gabapentin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2428792A1 (de) * 1974-06-14 1976-01-02 Knoll Ag Neue antiarrhythmika
LU76173A1 (fi) * 1976-11-11 1978-07-10
DE2658558A1 (de) * 1976-12-23 1978-06-29 Bayer Ag Diazabicyclo(3,3,1)nonane, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2726571A1 (de) * 1977-06-13 1978-12-21 Basf Ag Neue bispidinderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten

Also Published As

Publication number Publication date
IE832186L (en) 1984-03-18
NO160516B (no) 1989-01-16
DK422583D0 (da) 1983-09-16
NO160516C (no) 1989-04-26
DD213923A5 (de) 1984-09-26
JPS5970686A (ja) 1984-04-21
PT77344A (en) 1983-10-01
SU1272989A3 (ru) 1986-11-23
DK165833B (da) 1993-01-25
IL69751A (en) 1986-10-31
DE3380409D1 (de) 1989-09-21
EP0250903B1 (de) 1991-11-27
EP0250903A3 (en) 1988-03-09
CS389891A3 (en) 1992-07-15
IL69751A0 (en) 1983-12-30
FI76338B (fi) 1988-06-30
UA817A1 (uk) 1993-12-15
ES525653A0 (es) 1984-06-01
JPH05247039A (ja) 1993-09-24
CA1254209A (en) 1989-05-16
FI833339A0 (fi) 1983-09-19
EP0103833B1 (de) 1989-08-16
FI833339A (fi) 1984-03-19
MX9202996A (es) 1992-07-01
EP0103833A3 (en) 1984-11-28
ATE45579T1 (de) 1989-09-15
ZA836185B (en) 1984-04-25
ES8405398A1 (es) 1984-06-01
US4742172A (en) 1988-05-03
NZ205627A (en) 1985-11-08
DK422583A (da) 1984-03-19
IE57580B1 (en) 1993-01-13
EP0250903A2 (de) 1988-01-07
GEP19960316B (en) 1996-06-24
US4550112A (en) 1985-10-29
ATE69817T1 (de) 1991-12-15
NO833346L (no) 1984-03-19
DK165833C (da) 1993-06-21
DE3234697A1 (de) 1984-03-22
AU564910B2 (en) 1987-09-03
HU191096B (en) 1987-01-28
EP0103833A2 (de) 1984-03-28
CA1259998C (fi) 1989-09-26
DE3382466D1 (de) 1992-01-09
PT77344B (en) 1986-03-11
GR78722B (fi) 1984-10-02
JPH0670056B2 (ja) 1994-09-07
AU1920683A (en) 1984-03-22
FI76338C (fi) 1988-10-10

Similar Documents

Publication Publication Date Title
PH20768A (en) New diazabicyclo-(3.3.1)-nonanes and a process for the preparation thereof
ES2027550A6 (es) Procedimiento para preparar derivados de glicerol.
PT93126A (pt) Processo para a preparacao de eteres carboxialquilicos da 2-amino-7- -hidroxitetralina
YU43838B (en) Process for making new derivatives of n-imino-pyridinium betaine
DE3062340D1 (en) 1-n-alkylsisomicin derivatives, process for their preparation and their use as medicines
EP0257572A3 (en) Thyronin derivatives
DE3374005D1 (en) 1-methyl-5-nitro-imidazoline derivatives and therapeutic compositions which contain them as active principle
GR3003656T3 (fi)
ES8702392A1 (es) Un procedimiento para preparar compuestos heterociclicos, en particular compuestos con un anillo de tiadiazinona
PL246418A1 (en) Process for preparing n-/3-trifluoromethylphenyl/-n'-propargylpiperazine
DE3269505D1 (en) Substituted 1-benzoyl-2-phenylimino-imidazolidines, their acid addition salts, process for their preparation and pharmaceutical compositions containing them
AU573062B2 (en) Dihydrodithiazine derivatives
ZA86543B (en) 2-alkoxycarbonylalkyl-3-oxo-5,6-diaryl-as-triazines having utility as therapeutics
HUT60495A (en) Process for producing ergoline derivatives and pharmaceutical compositions comprising such compounds
ES8407047A1 (es) Un procedimiento para la preparacion de un compuesto de 5-aril-1,2,3,4-tetrahidro-y-carbolina-2-sustituida.
ES8105713A1 (es) Un procedimiento para la preparacion de los enatiomeros levogiro y dextrogiro de la 1-ciclopropil-metil-4-(3-metoxi-5h- dibenzo (a,d) ciclohepten-5-iliden) piperidina